These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23351743)

  • 21. Analysis of GPCR dimerization using acceptor photobleaching resonance energy transfer techniques.
    Busnelli M; Mauri M; Parenti M; Chini B
    Methods Enzymol; 2013; 521():311-27. PubMed ID: 23351747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of GPCR dimerisation/oligomerisation in receptor signalling.
    Milligan G; Canals M; Pediani JD; Ellis J; Lopez-Gimenez JF
    Ernst Schering Found Symp Proc; 2006; (2):145-61. PubMed ID: 17703581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional diversity of signaling pathways through G protein-coupled receptor heterodimerization with a species-specific orphan receptor subtype.
    Sakai T; Aoyama M; Kusakabe T; Tsuda M; Satake H
    Mol Biol Evol; 2010 May; 27(5):1097-106. PubMed ID: 20026483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis.
    Laroche G; Lépine MC; Thériault C; Giguère P; Giguère V; Gallant MA; de Brum-Fernandes A; Parent JL
    Cell Signal; 2005 Nov; 17(11):1373-83. PubMed ID: 15893915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chapter 10. Hetero-oligomerization of chemokine receptors.
    Appelbe S; Milligan G
    Methods Enzymol; 2009; 461():207-25. PubMed ID: 19480921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D4 receptor oligomerization--contribution to receptor biogenesis.
    Van Craenenbroeck K; Borroto-Escuela DO; Romero-Fernandez W; Skieterska K; Rondou P; Lintermans B; Vanhoenacker P; Fuxe K; Ciruela F; Haegeman G
    FEBS J; 2011 Apr; 278(8):1333-44. PubMed ID: 21320289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GRIP: a server for predicting interfaces for GPCR oligomerization.
    Nemoto W; Fukui K; Toh H
    J Recept Signal Transduct Res; 2009 Dec; 29(6):312-7. PubMed ID: 19888901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
    Ecke D; Hanck T; Tulapurkar ME; Schäfer R; Kassack M; Stricker R; Reiser G
    Biochem J; 2008 Jan; 409(1):107-16. PubMed ID: 17824841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization.
    Ayoub MA; Pfleger KD
    Curr Opin Pharmacol; 2010 Feb; 10(1):44-52. PubMed ID: 19897419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor homo- and heterodimerization.
    Mackie K
    Life Sci; 2005 Aug; 77(14):1667-73. PubMed ID: 15978631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling.
    Lohse MJ; Nuber S; Hoffmann C
    Pharmacol Rev; 2012 Apr; 64(2):299-336. PubMed ID: 22407612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.
    James JR; Oliveira MI; Carmo AM; Iaboni A; Davis SJ
    Nat Methods; 2006 Dec; 3(12):1001-6. PubMed ID: 17086179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time monitoring of receptor and G-protein interactions in living cells.
    Galés C; Rebois RV; Hogue M; Trieu P; Breit A; Hébert TE; Bouvier M
    Nat Methods; 2005 Mar; 2(3):177-84. PubMed ID: 15782186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology.
    Maggio R; Novi F; Scarselli M; Corsini GU
    FEBS J; 2005 Jun; 272(12):2939-46. PubMed ID: 15955054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hetero-oligomerization of chemokine receptors: diversity and relevance for function.
    Kraemer S; Alampour-Rajabi S; El Bounkari O; Bernhagen J
    Curr Med Chem; 2013; 20(20):2524-36. PubMed ID: 23432589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization.
    Karip E; Turu G; Süpeki K; Szidonya L; Hunyady L
    Neurochem Int; 2007 Oct; 51(5):261-7. PubMed ID: 17644220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitements and challenges in GPCR oligomerization: molecular insight from FRET.
    Chakraborty H; Chattopadhyay A
    ACS Chem Neurosci; 2015 Jan; 6(1):199-206. PubMed ID: 25363209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
    Guo X; Li Q; Pi S; Xia Y; Mao L
    Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.
    Łukasiewicz S; Faron-Górecka A; Kędracka-Krok S; Dziedzicka-Wasylewska M
    Eur J Pharmacol; 2011 Jun; 659(2-3):114-23. PubMed ID: 21496455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.